BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+17%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$2.04B
AUM Growth
+$2.04B
Cap. Flow
+$64.9M
Cap. Flow %
3.19%
Top 10 Hldgs %
54.88%
Holding
72
New
11
Increased
1
Reduced
5
Closed
4

Top Buys

1
TIL icon
Instil Bio
TIL
$23.9M
2
KYMR icon
Kymera Therapeutics
KYMR
$21.3M
3
NRIX icon
Nurix Therapeutics
NRIX
$12.7M
4
QURE icon
uniQure
QURE
$11M
5
APGE icon
Apogee Therapeutics
APGE
$10.5M

Top Sells

1
FATE icon
Fate Therapeutics
FATE
$11.4M
2
ALLO icon
Allogene Therapeutics
ALLO
$8.97M
3
NKTX icon
Nkarta
NKTX
$7.13M
4
PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
$7.08M
5
AMLX icon
Amylyx Pharmaceuticals
AMLX
$2.85M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$7.1B
$194M 9.52% 4,279,464 – –
TYRA icon
2
Tyra Biosciences
TYRA
$675M
$152M 7.44% 6,448,359 – –
NUVL icon
3
Nuvalent
NUVL
$5.52B
$115M 5.62% 1,120,192 – –
ONC
4
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$112M 5.51% 500,000 – –
CYTK icon
5
Cytokinetics
CYTK
$4.23B
$111M 5.44% 2,100,000 – –
SWTX
6
DELISTED
SpringWorks Therapeutics
SWTX
$110M 5.38% 3,421,541 – –
MRUS icon
7
Merus
MRUS
$4.98B
$94.9M 4.66% 1,900,000 – –
SRPT icon
8
Sarepta Therapeutics
SRPT
$1.78B
$81.2M 3.98% 650,000 – –
RNA icon
9
Avidity Biosciences
RNA
$5.99B
$79.3M 3.89% 1,727,388 – –
IDYA icon
10
IDEAYA Biosciences
IDYA
$2.15B
$69.8M 3.42% 2,202,812 – –
TNGX icon
11
Tango Therapeutics
TNGX
$747M
$63.1M 3.1% 8,198,642 – –
ARGX icon
12
argenx
ARGX
$43.6B
$54.2M 2.66% 100,000 – –
APLS icon
13
Apellis Pharmaceuticals
APLS
$3.48B
$49.8M 2.44% 1,726,000 – –
AKRO icon
14
Akero Therapeutics
AKRO
$3.74B
$48.1M 2.36% 1,676,733 – –
ANAB icon
15
AnaptysBio
ANAB
$569M
$43.6M 2.14% 1,300,000 – –
AXSM icon
16
Axsome Therapeutics
AXSM
$6.05B
$35.9M 1.76% 400,000 – –
ITOS icon
17
iTeos Therapeutics
ITOS
$30.1M 1.48% 2,946,915 – –
LEGN icon
18
Legend Biotech
LEGN
$6.41B
$29.2M 1.43% 600,000 – –
GERN icon
19
Geron
GERN
$893M
$27.2M 1.34% 6,000,000 – –
THRD
20
DELISTED
Third Harmonic Bio
THRD
$27.1M 1.33% 2,000,000 – –
RCKT icon
21
Rocket Pharmaceuticals
RCKT
$354M
$27.1M 1.33% 1,466,051 – –
RCUS icon
22
Arcus Biosciences
RCUS
$1.13B
$24.5M 1.2% 1,602,200 – –
TIL icon
23
Instil Bio
TIL
$182M
$23.9M 1.17% +355,500 New +$23.9M
XENE icon
24
Xenon Pharmaceuticals
XENE
$2.98B
$23.6M 1.16% 600,000 – –
IMVT icon
25
Immunovant
IMVT
$2.56B
$23.5M 1.15% 825,000 – –
1
2 3